Iane de Oliveira Pires Porto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Iane de Oliveira Pires Porto has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Aguinaldo Figueiredo Freitas
Universidade Federal de Goiás
1 shared publication - Ana Luísa Guedes de França-E-Silva
Faculdade de Medicina, Departamento de Clínica Médica, Universidade Federal de Goiás (UFG), Goiânia 74020-020, Brazil
1 shared publication - Antonio da Silva Menezes Junior
Internal Medicine Department, Faculty of Medicine, Federal University of Goiás, Goiânia 74690-900, Goiás, Brazil
1 shared publication Daniela de Melo e Silva
Universidade Federal de Goiás
1 shared publication- Daniela de Melo e Silva
Laboratório de Mutagênese (LabMut), Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, Brazil
1 shared publication Fernanda Ribeiro Godoy
Laboratório BioVida DNA
1 shared publication
Latest Publications
- Open Access
- 28 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 5855
Genetic Mutations and Mitochondrial Redox Signaling as Modulating Factors in Hypertrophic Cardiomyopathy: A Scoping Review
Hypertrophic cardiomyopathy (HCM) is a heart condition characterized by cellular and metabolic dysfunction, with mitochondrial dysfunction playing a crucial role. Although the direct relationship between genetic mutations and mitochondrial dysfunction remains unclear, targeting mitochondrial dysfunction presents promising opportunities for treatment, as there are currently no effective treatments available for HCM. This review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews guidelines. Searches were conducted in databases such as PubMed, Embase, and Scopus up to September 2023 using “MESH terms”. Bibliographic references from pertinent articles were also included. Hypertrophic cardiomyopathy (HCM) is influenced by ionic homeostasis, cardiac tissue remodeling, metabolic balance, genetic mutations, reactive oxygen species regulation, and mitochondrial dysfunction. The latter is a common factor regardless of the cause and is linked to intracellular calcium handling, energetic and oxidative stress, and HCM-induced hypertrophy. Hypertrophic cardiomyopathy treatments focus on symptom management and complication prevention. Targeted therapeutic approaches, such as improving mitochondrial bioenergetics, are being explored. This includes coenzyme Q and elamipretide therapies and metabolic strategies like therapeutic ketosis. Understanding the biomolecular, genetic, and mitochondrial mechanisms underlying HCM is crucial for developing new therapeutic modalities.
- 28 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 5855
Open AccessGenetic Mutations and Mitochondrial Redox Signaling as Modulating Factors in Hypertrophic Cardiomyopathy: A Scoping Review
Hypertrophic cardiomyopathy (HCM) is a heart condition characterized by cellular and metabolic dysfunction, with mitochondrial dysfunction playing a crucial role. Although the direct relationship between genetic mutations and mitochondrial dysfunction remains unclear, targeting mitochondrial dysfunction presents promising opportunities for treatment, as there are currently no effective treatments available for HCM. This review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews guidelines. Searches were conducted in databases such as PubMed, Embase, and Scopus up to September 2023 using “MESH terms”. Bibliographic references from pertinent articles were also included. Hypertrophic cardiomyopathy (HCM) is influenced by ionic homeostasis, cardiac tissue remodeling, metabolic balance, genetic mutations, reactive oxygen species regulation, and mitochondrial dysfunction. The latter is a common factor regardless of the cause and is linked to intracellular calcium handling, energetic and oxidative stress, and HCM-induced hypertrophy. Hypertrophic cardiomyopathy treatments focus on symptom management and complication prevention. Targeted therapeutic approaches, such as improving mitochondrial bioenergetics, are being explored. This includes coenzyme Q and elamipretide therapies and metabolic strategies like therapeutic ketosis. Understanding the biomolecular, genetic, and mitochondrial mechanisms underlying HCM is crucial for developing new therapeutic modalities.
- Open Access
- 11 October 2023
- Published by Springer Nature in Research Square
Exploring the Utility of Expanded Clinical Exome Sequencing in Cancer Patients with Pesticide Exposure: Insights from Blood Samples
Brazil is a major pesticide consumer with evident problems in regulation and supervision of such products. Thus, evaluating the impact of pesticides on human health is pivotal to understanding their relationship with disease development and progression. In this context, we aimed to assess a panel of molecular pathways associated with cancer susceptibility, as well as the exposure and lifestyle profile of a group of Brazilian farmers occupationally exposed to pesticides. We performed a clinical exome sequencing in 31 farmers diagnosed with cancer presenting a history of pesticide exposure. Using the Emedgene software (Illumina), we categorized a compilation of candidate disease-related genes and evaluated them to discern crucial pathways associated with carcinogenesis. Consequently, we successfully pinpointed a group of genes that should be regarded as potential risk factors when exposed to a carcinogenic environment. Our analysis suggests an important role of extracellular matrix related pathways in cancer susceptibility, along with some classical findings such as genes related to DNA repair mechanisms. The tumor microenvironment emerges as a promising area of investigation and, future studies should consider its impact on cancer development and progression.
- 11 October 2023
- Published by Springer Nature in Research Square
Open AccessExploring the Utility of Expanded Clinical Exome Sequencing in Cancer Patients with Pesticide Exposure: Insights from Blood Samples
Brazil is a major pesticide consumer with evident problems in regulation and supervision of such products. Thus, evaluating the impact of pesticides on human health is pivotal to understanding their relationship with disease development and progression. In this context, we aimed to assess a panel of molecular pathways associated with cancer susceptibility, as well as the exposure and lifestyle profile of a group of Brazilian farmers occupationally exposed to pesticides. We performed a clinical exome sequencing in 31 farmers diagnosed with cancer presenting a history of pesticide exposure. Using the Emedgene software (Illumina), we categorized a compilation of candidate disease-related genes and evaluated them to discern crucial pathways associated with carcinogenesis. Consequently, we successfully pinpointed a group of genes that should be regarded as potential risk factors when exposed to a carcinogenic environment. Our analysis suggests an important role of extracellular matrix related pathways in cancer susceptibility, along with some classical findings such as genes related to DNA repair mechanisms. The tumor microenvironment emerges as a promising area of investigation and, future studies should consider its impact on cancer development and progression.
- Open Access
- 1 January 2020
- Published by Brazilian Journal of Health Review in Brazilian Journal of Health Review
- Vol. 3 (2) , 1676-1681
Análise da fisiopatologia e impactos da criptorquidia em crianças e adolescentes: uma revisão bibliográfica
A criptorquidia ocorre quando o testículo não é palpável na bolsa escrotal devido a uma anomalia congênita. No início do desenvolvimento embrionário os testículos têm localização lombar e por volta do 7° mês da gestação deveria completar a descida até o saco escrotal, o que não acontece nesse caso. O objetivo dessa pesquisa é identificar os possíveis impactos que essa anomalia pode gerar nas crianças e adolescentes e sua evolução clínica. Para isso foi realizada uma revisão bibliográfica integrativa da literatura atualizada utilizando artigos dos bancos de dados Scientific Electronic Library Online (SciELO), Medline e Google Acadêmico, e também a literatura médica clássica. No que diz respeito aos impactos da criptorquidia pode-se citar o atraso no processo de desenvolvimento que leva o corpo a maturidade sexual e uma disfunção no crescimento tanto em estatura quanto em massa corpórea. Além disso, essa patologia é um importante fator de risco na vida adulta para a apresentação de infertilidade e malignização. Dessa forma, é imprescindível salientar a importância da atenção médica no exame físico dos recém-natos, visto que a detecção precoce é um fator essencial para obtenção não só de um melhor prognóstico, mas também para a prevenção de um futuro problema psicossocial advindo dos impactos físicos e mentais da criptorquidia.
- 1 January 2020
- Published by Brazilian Journal of Health Review in Brazilian Journal of Health Review
- Vol. 3 (2) , 1676-1681
Open AccessAnálise da fisiopatologia e impactos da criptorquidia em crianças e adolescentes: uma revisão bibliográfica
A criptorquidia ocorre quando o testículo não é palpável na bolsa escrotal devido a uma anomalia congênita. No início do desenvolvimento embrionário os testículos têm localização lombar e por volta do 7° mês da gestação deveria completar a descida até o saco escrotal, o que não acontece nesse caso. O objetivo dessa pesquisa é identificar os possíveis impactos que essa anomalia pode gerar nas crianças e adolescentes e sua evolução clínica. Para isso foi realizada uma revisão bibliográfica integrativa da literatura atualizada utilizando artigos dos bancos de dados Scientific Electronic Library Online (SciELO), Medline e Google Acadêmico, e também a literatura médica clássica. No que diz respeito aos impactos da criptorquidia pode-se citar o atraso no processo de desenvolvimento que leva o corpo a maturidade sexual e uma disfunção no crescimento tanto em estatura quanto em massa corpórea. Além disso, essa patologia é um importante fator de risco na vida adulta para a apresentação de infertilidade e malignização. Dessa forma, é imprescindível salientar a importância da atenção médica no exame físico dos recém-natos, visto que a detecção precoce é um fator essencial para obtenção não só de um melhor prognóstico, mas também para a prevenção de um futuro problema psicossocial advindo dos impactos físicos e mentais da criptorquidia.